BDBM400815 QL-XI-13::US10000483, Compound II-8

SMILES C=CC(=O)Nc1cccc(c1)-n1c2c(ccc1=O)cnc1ccc(cc21)-c1cn[nH]c1

InChI Key InChIKey=COWVAFPFSREMEQ-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 400815   

TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400815(QL-XI-13 | US10000483, Compound II-8)
Affinity DataIC50: 10.5nMAssay Description:Purified BMX was mixed with substrate (FAK or Bmxtides), kinase buffer (final 20 mM HEPES, pH 7.5, 10 mM MgCl2, 20 mM β-glycerophosphate, 1 mM d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400815(QL-XI-13 | US10000483, Compound II-8)
Affinity DataIC50: 18nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400815(QL-XI-13 | US10000483, Compound II-8)
Affinity DataIC50: 11nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400815(QL-XI-13 | US10000483, Compound II-8)
Affinity DataIC50: 41nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Blk(Human)
University of Science and Technology of China

Curated by ChEMBL
LigandPNGBDBM400815(QL-XI-13 | US10000483, Compound II-8)
Affinity DataIC50: 293nMAssay Description:Inhibition of recombinant full length His-tagged human BLK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400815(QL-XI-13 | US10000483, Compound II-8)
Affinity DataIC50: 18nMAssay Description:Inhibition of BTK autophosphorylation at Y223 in anti-IgM stimulated human MOLM13 cells after 4 hrs by chemiluminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
University of Science and Technology of China

Curated by ChEMBL
LigandPNGBDBM400815(QL-XI-13 | US10000483, Compound II-8)
Affinity DataIC50: 224nMAssay Description:Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2020
Entry Details Article
PubMed
TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400815(QL-XI-13 | US10000483, Compound II-8)
Affinity DataIC50: 11nMAssay Description:Inhibition of recombinant full length His-tagged human BMX expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2020
Entry Details Article
PubMed